Industry: Biotechnology (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-06-13 | New | Yet to Sell | $0 | Equity Only | 06c | SEC link |
2022-07-26 | New | $250,000 | $250,000 | Debt Only | 06c | SEC link |
Name | Role |
---|---|
Charles Avery Fisher | Director |
Kelly Joseph Roman | Director, Executive |
Simon Webster | Director |